IS7789A - Vatnsleysanlegir fjölliðualkanalar - Google Patents

Vatnsleysanlegir fjölliðualkanalar

Info

Publication number
IS7789A
IS7789A IS7789A IS7789A IS7789A IS 7789 A IS7789 A IS 7789A IS 7789 A IS7789 A IS 7789A IS 7789 A IS7789 A IS 7789A IS 7789 A IS7789 A IS 7789A
Authority
IS
Iceland
Prior art keywords
water
soluble polymer
polymer channels
channels
soluble
Prior art date
Application number
IS7789A
Other languages
English (en)
Inventor
Kozlowski Antoni
Original Assignee
Nektar Therapeutics Al, Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al, Corporation filed Critical Nektar Therapeutics Al, Corporation
Publication of IS7789A publication Critical patent/IS7789A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7789A 2002-09-09 2005-04-08 Vatnsleysanlegir fjölliðualkanalar IS7789A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40925102P 2002-09-09 2002-09-09
US45658003P 2003-03-19 2003-03-19
PCT/US2003/028221 WO2004022630A2 (en) 2002-09-09 2003-09-09 Water-soluble polymer alkanals

Publications (1)

Publication Number Publication Date
IS7789A true IS7789A (is) 2005-04-08

Family

ID=31981629

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7789A IS7789A (is) 2002-09-09 2005-04-08 Vatnsleysanlegir fjölliðualkanalar

Country Status (22)

Country Link
US (5) US7157546B2 (is)
EP (1) EP1546235B1 (is)
JP (2) JP4764630B2 (is)
KR (2) KR100974843B1 (is)
AP (2) AP2005003246A0 (is)
AU (1) AU2003270454B2 (is)
BR (1) BR0314172A (is)
CA (1) CA2498167C (is)
EA (1) EA200500475A1 (is)
EC (1) ECSP055654A (is)
ES (1) ES2897470T3 (is)
GE (1) GEP20074193B (is)
HR (2) HRP20050320A2 (is)
IS (1) IS7789A (is)
MA (1) MA27401A1 (is)
MX (1) MXPA05002620A (is)
NO (2) NO20051077L (is)
NZ (2) NZ540490A (is)
PL (1) PL375883A1 (is)
RS (2) RS20050202A (is)
UA (1) UA80838C2 (is)
WO (1) WO2004022630A2 (is)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
SI3025726T1 (sl) 2002-01-18 2020-03-31 Biogen Ma Inc. Spojine polimera polialkilena in njihova uporaba
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
NZ540490A (en) * 2002-09-09 2007-10-26 Nektar Therapeutics Al Corp Water-soluble polymer alkanal conjugates with human growth hormone
KR101045401B1 (ko) 2002-09-11 2011-06-30 프레제니우스 카비 도이치란트 게엠베하 하이드록시알킬 전분 유도체
PL396711A1 (pl) * 2002-12-26 2011-12-19 Mountain View Pharmaceuticals, Inc. Koniugaty polimerów z cytokinami, chemokinami, czynnikami wzrostu, hormonami polipeptydowymi i ich antagonistami, kompozycja farmaceutyczna i sposób zapobiegania, diagnozowania lub leczenia
NZ541124A (en) * 2002-12-26 2008-08-29 Mountain View Pharmaceuticals Polymer conjugates of interferon-beta with enhanced biological potency
EP2572732A1 (en) * 2003-02-26 2013-03-27 Nektar Therapeutics Polymer-factor VIII moiety conjugates
US7947261B2 (en) 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
SG145746A1 (en) * 2003-08-08 2008-09-29 Fresenius Kabi De Gmbh Conjugates of hydroxyalkyl starch and g-csf
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AR048035A1 (es) * 2004-03-11 2006-03-22 Fresenius Kabi De Gmbh Conjugados de almidon de hidroxialquilo y una proteina, preparados por aminacion reductora
CN1929865B (zh) * 2004-03-11 2011-11-16 费森尤斯卡比德国有限公司 羟烷基淀粉和蛋白质的接合物
JP4805911B2 (ja) 2004-03-15 2011-11-02 ネクター セラピューティクス Ｈｉｖ侵入阻害剤のポリマー系組成物及び複合体
WO2005094898A2 (en) * 2004-03-23 2005-10-13 Amgen Inc. Chemically modified protein compositions and methods
EP1768700B1 (en) * 2004-07-16 2010-12-15 Nektar Therapeutics Conjugates comprising gm-csf and a polymer
BRPI0515118A (pt) * 2004-08-31 2008-07-01 Pharmacia & Upjohn Co Llc conjugados de hormÈnio do crescimento humano com polietileno glicol
CA2584510C (en) * 2004-10-25 2013-05-28 Intezyne Technologies, Incorporated Heterobifunctional poly(ethylene glycol) and uses thereof
AU2006222187A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
WO2007010552A2 (en) * 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
US20060233740A1 (en) * 2005-03-23 2006-10-19 Bossard Mary J Conjugates of an hGH moiety and a polymer
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
EP2364735A3 (en) 2005-12-16 2012-04-11 Nektar Therapeutics Branched PEG conjugates of GLP-1
EP1834963A1 (en) * 2006-03-13 2007-09-19 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
EP2010477A4 (en) 2006-04-27 2012-05-30 Intezyne Technologies Inc POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDOGROUP
CL2008002399A1 (es) * 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
EP2070951A1 (en) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Method for producing a hydroxyalkyl starch derivatives with two linkers
JP5704925B2 (ja) * 2008-02-08 2015-04-22 ウェルズ ファーゴ バンク ナショナル アソシエイション オリゴマー−カンナビノイドコンジュゲート
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
EP2313457B1 (en) 2008-07-31 2020-01-15 PharmaEssentia Corp. Peptide-polymer conjugates
WO2010030366A2 (en) * 2008-09-11 2010-03-18 Nektar Therapeutics Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
MX2011003117A (es) * 2008-09-19 2011-04-21 Nektar Therapeutics Conjugados polimericos de peptidos terapeuticos.
EP2344200A2 (en) * 2008-09-19 2011-07-20 Nektar Therapeutics Modified therapeutics peptides, methods of their preparation and use
GB0823309D0 (en) * 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
KR20180000337A (ko) * 2009-07-14 2018-01-02 노파르티스 아게 중간엽 줄기 세포 분화
MX2012013375A (es) 2010-05-17 2013-04-11 Cebix Inc Peptido c pegilado.
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
WO2012054822A1 (en) 2010-10-22 2012-04-26 Nektar Therapeutics Pharmacologically active polymer-glp-1 conjugates
HUE054318T2 (hu) * 2010-11-12 2021-08-30 Nektar Therapeutics IL-2 molekularész konjugátumai és polimer
EP2540325B1 (en) * 2011-06-27 2016-08-10 Greatbatch Ltd. Peptide based antimicrobial coating
EP2592103A1 (en) * 2011-11-08 2013-05-15 Adriacell S.p.A. Polymer aldehyde derivatives
EP2792698A4 (en) * 2011-12-14 2015-12-23 Univ Tsukuba NOVEL BRANCHED POLYETHYLENE GLYCOL AND USE THEREOF
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
JP6106104B2 (ja) 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法
JP6106103B2 (ja) 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法、並びにこれに用いる新規なアセタール基含有アルコール化合物及びそのアルカリ金属塩
GB201419108D0 (en) 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
FI3215193T3 (fi) 2014-11-06 2023-12-28 Pharmaessentia Corp Pegyloidun interferonin annostusohjelma
WO2017062832A1 (en) 2015-10-08 2017-04-13 Nektar Therapeutics Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002531A (en) * 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
JPS5695142A (en) * 1979-12-28 1981-08-01 T Hasegawa Co Ltd Preparation of aliphatic aldehyde
US5037969A (en) * 1986-07-03 1991-08-06 Takeda Chemical Industries, Ltd. Glycosyl derivatives and use thereof
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
AU4660789A (en) 1988-11-23 1990-06-12 Genentech Inc. Polypeptide derivatives
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JPH06233816A (ja) 1993-02-12 1994-08-23 Toyobo Co Ltd 血液浄化吸着材
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5627662A (en) * 1994-04-28 1997-05-06 Xerox Corporation Digital imaging system using two-dimensional input sensor array and output light valve
FR2724459B1 (fr) 1994-09-14 1997-05-09 Univ Compiegne Tech Electrophorese capillaire d'affinite, matrice d'affinite pour la mise en oeuvre de cette electrophorese et son procede de fabrication
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
JPH11322916A (ja) 1998-05-11 1999-11-26 Kazunori Kataoka ビオチン残基を片末端に有するヘテロテレケリツクポリマー
US6420555B1 (en) * 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
AU1325400A (en) * 1998-10-26 2000-05-15 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
AU2346900A (en) 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
JP2000303090A (ja) * 1999-04-20 2000-10-31 T Hasegawa Co Ltd 香料組成物
JP4861586B2 (ja) * 1999-12-22 2012-01-25 ネクター セラピューティックス 水溶性ポリマーの立体的に妨害される誘導体
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
MXPA04004336A (es) 2001-11-07 2005-05-16 Nektar Therapeutics Al Corp Polimeros ramificados y sus conjugados.
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
AP2004003050A0 (en) 2001-11-20 2004-06-30 Pharmacia Corp Chemically modified human growth hormone conjugates
US6916962B2 (en) * 2001-12-11 2005-07-12 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
US6956135B2 (en) * 2001-12-11 2005-10-18 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
AU2002357806A1 (en) 2001-12-11 2003-06-23 Sun Bio, Inc. Novel monofunctional polyethylene glycol aldehydes
SI3025726T1 (sl) 2002-01-18 2020-03-31 Biogen Ma Inc. Spojine polimera polialkilena in njihova uporaba
EP1503367A4 (en) * 2002-04-26 2007-05-30 Prime Polymer Co Ltd SOUND ABSORBING BODY, SOUND ABSORBING STRUCTURAL BODY AND METHOD FOR THE PRODUCTION THEREOF
DK1539857T3 (da) * 2002-07-24 2007-03-12 Hoffmann La Roche Polyethylenglycol-aldehydderivater
NZ540490A (en) * 2002-09-09 2007-10-26 Nektar Therapeutics Al Corp Water-soluble polymer alkanal conjugates with human growth hormone
TWI281864B (en) * 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
US20040142870A1 (en) * 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
US6961962B1 (en) * 2004-09-09 2005-11-08 Morning Pride Manufacturing, L.L.C. Combined closure and liner zippers employing common zipper tapes and protective garment employing said combined zippers
JP5084245B2 (ja) 2006-06-07 2012-11-28 関西ペイント株式会社 澱粉系塗料組成物

Also Published As

Publication number Publication date
UA80838C2 (en) 2007-11-12
US20040116649A1 (en) 2004-06-17
EA200500475A1 (ru) 2005-10-27
US8853325B2 (en) 2014-10-07
EP1546235A2 (en) 2005-06-29
NZ538624A (en) 2007-01-26
KR20050093856A (ko) 2005-09-23
NZ540490A (en) 2007-10-26
HRP20050319A2 (en) 2006-12-31
HRP20050320A2 (en) 2006-12-31
MXPA05002620A (es) 2005-05-05
WO2004022630A3 (en) 2004-04-15
BR0314172A (pt) 2005-07-26
AP2005003246A0 (en) 2005-03-31
RS20050202A (en) 2007-08-03
GEP20074193B (en) 2007-09-10
NO20051077L (no) 2005-04-08
WO2004022630A2 (en) 2004-03-18
US20120065429A1 (en) 2012-03-15
CA2498167A1 (en) 2004-03-18
EP1546235B1 (en) 2021-10-20
AU2003270454A1 (en) 2004-03-29
JP4764630B2 (ja) 2011-09-07
JP2005350470A (ja) 2005-12-22
JP2005538224A (ja) 2005-12-15
US8076412B2 (en) 2011-12-13
US20090234070A1 (en) 2009-09-17
RS20050203A (en) 2007-08-03
ES2897470T3 (es) 2022-03-01
KR100974843B1 (ko) 2010-08-11
ECSP055654A (es) 2005-05-30
US7157546B2 (en) 2007-01-02
US20110034737A1 (en) 2011-02-10
CA2498167C (en) 2012-03-20
US7511094B2 (en) 2009-03-31
US7838595B2 (en) 2010-11-23
NO20051078L (no) 2005-04-08
US20060194940A1 (en) 2006-08-31
AP2005003249A0 (en) 2005-03-31
AU2003270454B2 (en) 2010-05-20
PL375883A1 (en) 2005-12-12
KR20050057281A (ko) 2005-06-16
MA27401A1 (fr) 2005-06-01

Similar Documents

Publication Publication Date Title
IS7789A (is) Vatnsleysanlegir fjölliðualkanalar
DE602004020343D1 (de) Polymere
DE60330207D1 (de) le
DE60311291D1 (de) Polymerfestelektrolyt
DE60318035D1 (de) Polymermikroemulsionen
DE60312848D1 (de) Verbindungsanschluss
DE50311534D1 (de) Gewebeband-einrichtung
ATE318817T1 (de) Aza-arylpiperazine
DE60304683D1 (de) Auftrennwerkzeug
DE60319202D1 (de) Pigmentierte Polymerzusammensetzung
FI6928U1 (fi) Peliautomaatti
DE60315019D1 (de) Entfernbarer hydraulikschlauchträger
DE602004031170D1 (de) Druckmaschine
DE60207091D1 (de) Propylenpolymer
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
DE602004013003D1 (de) Halbleitendes Polymer
DE60310714D1 (de) Etonogestrelester
DE602004027813D1 (de) Blockcopolymerzusammensetzung
ATA1572002A (de) Managementspleisskassette
DE502004002647D1 (de) Polymernetzwerke
DE10209216B4 (de) Druckmaschine
DE60300961D1 (de) Vektorskop
IS7790A (is) Vatnsleysanlegir fjölliðualkanalar
BR0317312B1 (pt) adaptador.
EP1694092A4 (en) ACUTE SPEAKER